Dolutegravir D3 | CAS 2673270-25-0 - Request Quote
Dolutegravir D3
| SZ CAT No: | SZ-D052D02 |
| CAS No | 2673270-25-0 |
| Mol.F. | C20H16D3F2N3O5 |
| Mol.Wt. | 422.4 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1051375-16-6 (Unlabeled) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dolutegravir D3 is chemically (4R,12aS)-N-((2,4-difluorophenyl-3-d)methyl-d2)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide. Dolutegravir D3 is supplied with detailed characterization data compliant with regulatory guideline. Dolutegravir D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dolutegravir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2673270-25-0
Purchase 2673270-25-0
Order 2673270-25-0
Enquire 2673270-25-0
price of 2673270-25-0
2673270-25-0 Supplier
2673270-25-0 Manufacturer
2673270-25-0 Exporter
buy high quality Dolutegravir D3
Purchase Dolutegravir D3
Dolutegravir D3 suppliers
Dolutegravir D3 manufacturers
Dolutegravir D3 price
Order Dolutegravir D3
Enquire Dolutegravir D3
Dolutegravir D3 cost
Dolutegravir D3 Supplier
Dolutegravir D3 Distributor
Dolutegravir D3 for Method Validation
Dolutegravir Reference Standard
Dolutegravir D3 for ANDA Filing
Dolutegravir D3 for Forced Degradation Studies
Dolutegravir D3 Identification Standards
Dolutegravir D3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


